An Australian stem cell and regenerative medicine company

March 14, 2024

FNN interview with Dr Kilian Kelly

Off the back of a string of positive announcements - DFU trial initial data, new CBO and first patient treated in aGVHD trial - Cynata CEO Dr Kilian Kelly sat down with Finance News Network to discuss The Company's milestones. Watch the interview below

FNN Logo